Visit Us at Booth 481

ASGCT 26th Annual Meeting

May 16–20 | Los Angeles, CA

ASGCT 26th Annual Meeting

Join us at the American Society of Gene + Cell Therapy (ASGCT) Annual Meeting in Los Angeles, where we will be showcasing our cell and gene therapy capabilities, including immunoassays, flow cytometry, efficacy, and biodistribution in booth 481. The ASGCT Annual Meeting is the premier gathering of industry leaders and experts, and provides an unparalleled opportunity to learn from top researchers in the field while making valuable connections.

Noble’s experienced quality and regulatory experts specialize in Cell and Gene Therapy IND-enabling studies, and can ensure that your data is fully prepared for FDA submission. We are proud to be your partner to support your research efforts in the field of cell and gene therapy, and lead you through each critical process during this transformative journey towards bringing revolutionary advancements to patients worldwide!

Click here to schedule a meeting or stop by our booth 481 to speak with Chief Executive Officer, Srujana Cherukuri at the American Society of Gene + Cell Therapy Annual Meeting in Los Angeles from May 16-20.

We look forward to meeting you in Los Angeles!

Hybrid pharmacology/ toxicity/ activity studies

  • Pharmacodynamic marker analysis
  • Local and systemic toxicity
  • Histopathology

Inflammatory/immune response

  • Blood cytokine analysis
  • Immune system cellular response

Cell product characterization

  • Insertion site analysis
  • Transgene characterization

Biodistribution location and persistence of the product

  • Real time PCR
  • Flow Cytometry
  • Animal imaging

Meet Us There

Srujana Cherukuri, Ph.D

Chief Executive Officer

Edwin Gershom

Edwin Gershom, Ph.D.

Business Development Manager

Learn More About Noble’s Cell and Gene Therapy Services